Sorafenib (SFB) low dose in octogenarians with advanced or inoperable (a/i) HCC: Toxicity and efficacy evaluation.

Ignazio Carreca

Risultato della ricerca: Other › peer review

Fingerprint

Entra nei temi di ricerca di 'Sorafenib (SFB) low dose in octogenarians with advanced or inoperable (a/i) HCC: Toxicity and efficacy evaluation.'. Insieme formano una fingerprint unica.

Medicine & Life Sciences